Levocarnitine

Metabolic

Rx

Levocarnitine  

Levocarnitine

Rx

Active ingredient (INN)
levocarnitine
Composition (active ingredients)
levocarnitine - 100,0 mg; 200,0 mg
Фармакотерапевтическая группа
metabolic agent
Pharmacotherapeutic group
solution for intravenous and intramuscular injection 100 mg/ml 5 ml №5; 200 mg/ml 5 ml №5
Сonditions of supply
on prescription
Indications

Indications

  • as part of complex therapy for acute hypoxic conditions (acute cerebral hypoxia, ischemic stroke, transient ischemic attack). The drug is prescribed in the acute, subacute and recovery periods of cerebrovascular accidents
  • with discirculatory encephalopathy and various traumatic and toxic brain lesions, in the recovery period after surgery
  • with primary and secondary carnitine deficiency, including in patients with chronic renal failure on hemodialysis
  • with cardiomyopathy, ischemic heart disease (angina pectoris, acute myocardial infarction, postinfarction conditions), hypoperfusion due to cardiogenic shock and other metabolic disorders in the myocardium

Contraindications

There are contraindications, consult with a specialist before use